These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 11316178

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Cisapride does not modify prolonged Q-T interval in patients with liver cirrhosis].
    Quera R, Madrid AM, Ugalde H, Defilippi C.
    Rev Med Chil; 2000 Aug; 128(8):847-52. PubMed ID: 11129545
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Abnormalities in proximal small bowel motility in patients with cirrhosis.
    Chesta J, Defilippi C, Defilippi C.
    Hepatology; 1993 May; 17(5):828-32. PubMed ID: 8491451
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Investigation of autonomic function and orocecal transit time in patients with nonalcoholic cirrhosis and the potential influence of these factors on disease outcome.
    Nagasako CK, de Oliveira Figueiredo MJ, de Souza Almeida JR, Lorena SL, Akasaka HM, Pavan CR, Yamanaka A, Pereira TS, Soares EC, Mesquita MA.
    J Clin Gastroenterol; 2009 Oct; 43(9):884-9. PubMed ID: 19295446
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C, Läritz M, Meurer M, Endres SP, König A, Schindlbeck N.
    Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls.
    Chander Roland B, Garcia-Tsao G, Ciarleglio MM, Deng Y, Sheth A.
    J Clin Gastroenterol; 2013 Oct; 47(10):888-93. PubMed ID: 23632359
    [Abstract] [Full Text] [Related]

  • 14. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease.
    Pande C, Kumar A, Sarin SK.
    Aliment Pharmacol Ther; 2009 Jun 15; 29(12):1273-81. PubMed ID: 19302262
    [Abstract] [Full Text] [Related]

  • 15. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.
    Bauer TM, Steinbrückner B, Brinkmann FE, Ditzen AK, Schwacha H, Aponte JJ, Pelz K, Kist M, Blum HE.
    Am J Gastroenterol; 2001 Oct 15; 96(10):2962-7. PubMed ID: 11693333
    [Abstract] [Full Text] [Related]

  • 16. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK.
    J Gastroenterol Hepatol; 2005 Apr 15; 20(4):599-605. PubMed ID: 15836710
    [Abstract] [Full Text] [Related]

  • 17. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.
    Chang CS, Chen GH, Lien HC, Yeh HZ.
    Hepatology; 1998 Nov 15; 28(5):1187-90. PubMed ID: 9794900
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption.
    Shindo K, Machida M, Miyakawa K, Fukumura M.
    Am J Gastroenterol; 1993 Dec 15; 88(12):2084-91. PubMed ID: 8249977
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.